Sex specific familial risk in lung cancer through changing histologies in Sweden
International Journal of Cancer · 2025
DOI: 10.1002/ijc.35431 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Kari Hemminki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Cooperatio SURG and National Institute for Cancer Research-NICR, European Union-Next Generation EU and the SALVAGE Project, The Swedish Research Council, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations and Helsinki University Central Hospital.
Abstract (Originalsprache)
Familial clustering of lung cancer (LC) is related to shared smoking habits but the contribution of other potential factors such as sex or histology is not well known, and these are the subjects of the present study in Sweden. Family relationships (from Multigeneration register) and diagnosed cancers (from Cancer registry) were obtained from the national registers from 1961 to 2021. The overall familial risk for LC was constant from the 1990s but the male familial risk decreased while the female familial risk doubled at the same time when female incidence doubled. The female familial risk for mother‐daughter pairs was higher (SIR = 2.2 [2.0–2.3], N = 716) than for father‐son pairs (SIR = 1.6 [1.5–1.8], N = 962). The histology‐specific familial risks for adenocarcinoma, squamous cell carcinoma, small cell and large cell carcinoma were highest for concordant histology but also present for discordant histology. The number of family members diagnosed with LC was a strong determinant of familial risk. The novel results showed that familial risk of LC depends on the background incidence of LC and is higher for women compared to men. We demonstrated further an increased familial risk for each of the four histological types of LC which was higher for concordant than discordant histologies but was even detected between discordant histologies suggesting that LC histology is not a genetic trait.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biomedical Center, Faculty of Medicine, Charles University Pilsen, Pilsen, Czech Republic.
- Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Center for Primary Health Care Research, Lund University, Malmö, Sweden.
- University Clinic Primary Care Skåne, Skåne, Sweden.
- Department of Family and Community Medicine, McGovern Medical School, The University of Texas Health Science Center, Houston, Texas, USA.
- Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
ORCID-Profile: Kari Hemminki, Frantisek Zitricky, Akseli Hemminki
Förderung
- The Cooperatio SURG and National Institute for Cancer Research-NICR
- European Union-Next Generation EU and the SALVAGE Project
- The Swedish Research Council, Jane and Aatos Erkko Foundation, Sigrid Juselius Foundation, Finnish Cancer Organizations and Helsinki University Central Hospital
Zitieren
APA
Hemminki, K., Zitricky, F., Sundquist, K., Sundquist, J., Försti, A., & Hemminki, A. (2025). Sex specific familial risk in lung cancer through changing histologies in Sweden. International Journal of Cancer. https://doi.org/10.1002/ijc.35431
Vancouver
Hemminki K, Zitricky F, Sundquist K, Sundquist J, Försti A, Hemminki A. Sex specific familial risk in lung cancer through changing histologies in Sweden. International Journal of Cancer. 2025. doi:10.1002/ijc.35431
BibTeX
@article{Hemminki2025,
author = {Hemminki, Kari and Zitricky, Frantisek and Sundquist, Kristina and Sundquist, Jan and Försti, Asta and Hemminki, Akseli},
title = {Sex specific familial risk in lung cancer through changing histologies in Sweden},
journal = {International Journal of Cancer},
year = {2025},
doi = {10.1002/ijc.35431}
}
EUVIMED